These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mucosal delivery of vaccine antigens and its advantages in pediatrics. De Magistris MT Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335 [TBL] [Abstract][Full Text] [Related]
8. [The development of mucosal vaccines]. Bakke H; Haneberg B Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2818-21. PubMed ID: 17086224 [TBL] [Abstract][Full Text] [Related]
9. Rational design of Salmonella-based vaccination strategies. Spreng S; Dietrich G; Weidinger G Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270 [TBL] [Abstract][Full Text] [Related]
10. [Mucosal immunity and vaccine development]. Anjuère F; Czerkinsky C Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226 [TBL] [Abstract][Full Text] [Related]
11. [Oral vaccination and vaccine-entrapped microparticle delivery system]. Li FQ; Fei YB; Su H; Hu JH Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821 [TBL] [Abstract][Full Text] [Related]
12. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection. Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441 [TBL] [Abstract][Full Text] [Related]
13. Advances in transcutaneous vaccine delivery: do all ways lead to Rome? Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998 [TBL] [Abstract][Full Text] [Related]
14. Anomalous observations on IPV and OPV vaccination. John TJ Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328 [TBL] [Abstract][Full Text] [Related]
15. Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine. Nardelli-Haefliger D; Lurati F; Wirthner D; Spertini F; Schiller JT; Lowy DR; Ponci F; De Grandi P Vaccine; 2005 May; 23(28):3634-41. PubMed ID: 15882523 [TBL] [Abstract][Full Text] [Related]
16. Nasal vaccine innovation. Jabbal-Gill I J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271 [TBL] [Abstract][Full Text] [Related]
17. Mucosal vaccination--an old but still vital strategy. Długońska H; Grzybowski M Ann Parasitol; 2012; 58(1):1-8. PubMed ID: 23094329 [TBL] [Abstract][Full Text] [Related]
18. Vaccination by non-parenteral routes: characteristics of immune response. Ogra PL; Chiba Y; Beutner KR; Morag A Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968 [TBL] [Abstract][Full Text] [Related]
19. New insights in mucosal vaccine development. Pavot V; Rochereau N; Genin C; Verrier B; Paul S Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556 [TBL] [Abstract][Full Text] [Related]
20. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Glenn GM; Kenney RT; Ellingsworth LR; Frech SA; Hammond SA; Zoeteweij JP Expert Rev Vaccines; 2003 Apr; 2(2):253-67. PubMed ID: 12899576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]